本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Immunomedics

87.86
+0.0000
成交量:- -
成交額:- -
市值:203.24億
市盈率:-51.59
高:87.86
開:87.86
低:87.86
收:87.86
資料載入中...
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/26

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/23

重要事件披露

8-K - Current report
2020/10/23

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/09/21

重要事件披露

8-K - Current report
2020/09/17

重要事件披露

8-K - Current report
2020/09/14

重要事件披露

8-K - Current report